EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A genetically engineered mouse model for ovarian hyperstimulation syndrome

Wenkai Bi, Xinchen Jin, Shanshan Wu, Jing Wang, Xinhuan Su, Ling Gao, Zhao He

PeerJ · 2025

DOI: 10.7717/peerj.19531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Wenkai Bi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shandong Provincial Hospital & Medical Integration, and Practice Center, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Ovarian Hyperstimulation Syndrome, Disease Models, Animal, Follicle Stimulating Hormone. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian hyperstimulation syndrome (OHSS) is a common iatrogenic complication resulting from ovarian stimulation in assisted reproductive technology (ART). Excessive stimulation by follicle-stimulating hormone (FSH) has been recognized as a primary cause of OHSS. However, understanding the pathophysiological mechanisms of OHSS and developing effective drugs have been limited due to the absence of suitable animal models. In this study, we generated a FSH gene knock-in (FKI) mouse model to inducible FSH expression by the Tet-on system, that reflects the clinical manifestations of OHSS in patients. Upon administration of doxycycline (Dox), the FKI mice exhibited significantly elevated serum FSH levels compared to their wild-type (WT) littermate controls, accompanied by increased levels of estradiol (E2) and luteinizing hormone (LH), ovarian enlargement, and enhanced peritoneal permeability. Thus, the FKI mouse model is a valuable tool for studying OHSS, particularly dissecting the pathophysiological mechanism and developing potential prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian Hyperstimulation SyndromeDisease Models, AnimalFollicle Stimulating HormoneAnimalsFemaleMiceEstradiolLuteinizing HormoneMice, TransgenicDoxycyclineGene Knock-In TechniquesGenetic EngineeringMice, Inbred C57BL

Stichwörter der Autor:innen

Crisper-Cas9Follicle-stimulating hormoneOvarian hyperstimulation syndrome

Substanzen

Follicle Stimulating HormoneEstradiolLuteinizing HormoneDoxycycline

Autor:innen und Institutionen

  • Department of Endocrinology, Shandong Provincial Hospital & Medical Integration, and Practice Center, Shandong University, Jinan, Shandong, China.
  • Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Shandong Institute of Endocrine and Metabolic Diseases, Shan…
  • Department of Nuclear Medicine, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Endocrinology, Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Förderung

  • National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation

Zitieren

APA

Bi, W., Jin, X., Wu, S., Wang, J., Su, X., Gao, L., & He, Z. (2025). A genetically engineered mouse model for ovarian hyperstimulation syndrome. PeerJ. https://doi.org/10.7717/peerj.19531

Vancouver

Bi W, Jin X, Wu S, Wang J, Su X, Gao L, et al. A genetically engineered mouse model for ovarian hyperstimulation syndrome. PeerJ. 2025. doi:10.7717/peerj.19531

BibTeX
@article{Bi2025,
  author = {Bi, Wenkai and Jin, Xinchen and Wu, Shanshan and Wang, Jing and Su, Xinhuan and Gao, Ling and He, Zhao},
  title = {A genetically engineered mouse model for ovarian hyperstimulation syndrome},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19531}
}
Kostenlos starten →